Assessment of Pregabalin Efficacy for the Treatment and Prevention of At-level Non-evoked and Evoked Spinal Cord Injury Neuropathic Pain
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms LIIRA
- 23 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-000915-14).
- 23 Jun 2012 Comapny (Pfizer) added to the associations field as reported by European Clinical Trials Database record.
- 23 Jun 2012 Additional lead trial centre and investigator (Julian Taylor) identified as reported by European Clinical Trials Database record.